Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
12.07
-0.03 (-0.25%)
Jun 8, 2026, 4:00 PM EDT - Market closed
Medifast Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 124 | 117 | 193 | 732 | 1,254 | 2,428 | |
Market Cap Growth | -14.94% | -39.09% | -73.69% | -41.60% | -48.34% | 5.04% |
Enterprise Value | -29.09 | -43.8 | 40.33 | 598.52 | 1,187 | 2,344 |
Last Close Price | 12.07 | 10.68 | 17.62 | 67.22 | 115.35 | 209.43 |
PE Ratio | - | - | 92.74 | 7.39 | 9.06 | 15.08 |
Forward PE | - | - | - | 13.05 | 9.03 | 13.75 |
PEG Ratio | - | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 |
PS Ratio | 0.36 | 0.30 | 0.32 | 0.68 | 0.78 | 1.59 |
PB Ratio | 0.63 | 0.59 | 0.92 | 3.64 | 8.09 | 11.99 |
P/TBV Ratio | 0.67 | 0.59 | 0.92 | 3.64 | 8.39 | 12.22 |
P/FCF Ratio | - | 93.98 | 11.32 | 5.19 | 7.05 | 40.24 |
P/OCF Ratio | 33.29 | 17.10 | 7.87 | 4.96 | 6.45 | 25.68 |
EV/Sales Ratio | - | -0.11 | 0.07 | 0.56 | 0.74 | 1.54 |
EV/EBITDA Ratio | - | - | 2.59 | 4.29 | 6.06 | 10.51 |
EV/EBIT Ratio | - | 3.08 | 14.01 | 4.74 | 6.42 | 10.84 |
EV/FCF Ratio | - | - | 2.37 | 4.24 | 6.67 | 38.86 |
Debt / Equity Ratio | 0.06 | 0.03 | 0.05 | 0.08 | 0.13 | 0.13 |
Debt / EBITDA Ratio | - | 368.76 | 1.03 | 0.16 | 0.13 | 0.15 |
Debt / FCF Ratio | - | 8.56 | 0.95 | 0.16 | 0.15 | 0.54 |
Net Debt / Equity Ratio | -0.77 | -0.79 | -0.70 | -0.63 | -0.40 | -0.38 |
Net Debt / EBITDA Ratio | 84.91 | -5399.28 | -9.38 | -0.92 | -0.31 | -0.34 |
Net Debt / FCF Ratio | 103.91 | -125.36 | -8.59 | -0.91 | -0.35 | -1.28 |
Asset Turnover | 1.38 | 1.45 | 2.03 | 3.42 | 4.47 | 4.53 |
Inventory Turnover | 4.97 | 3.53 | 3.25 | 3.42 | 3.07 | 3.41 |
Quick Ratio | 4.00 | 3.89 | 2.53 | 1.63 | 0.62 | 0.65 |
Current Ratio | 4.80 | 4.69 | 3.34 | 2.43 | 1.58 | 1.81 |
Return on Equity (ROE) | -10.10% | -9.13% | 1.02% | 55.77% | 80.31% | 91.20% |
Return on Assets (ROA) | -16.05% | -17.69% | 0.53% | 31.17% | 40.35% | 48.67% |
Return on Invested Capital (ROIC) | -77.00% | -73.32% | 1.88% | 101.95% | 128.07% | 192.04% |
Return on Capital Employed (ROCE) | -7.83% | -6.69% | 1.32% | 64.34% | 91.53% | 109.98% |
Earnings Yield | - | - | 1.08% | 13.54% | 11.04% | 6.63% |
FCF Yield | - | 1.06% | 8.83% | 19.27% | 14.18% | 2.49% |
Dividend Yield | - | 0.17% | 0.37% | 9.98% | 5.55% | 2.60% |
Payout Ratio | - | -1.04% | 34.19% | 73.45% | 49.89% | 38.93% |
Buyback Yield / Dilution | -0.51% | -0.16% | -0.38% | 3.15% | 4.55% | 0.31% |
Total Shareholder Return | -0.51% | 0.00% | -0.01% | 13.13% | 10.09% | 2.92% |